[1] Efficacy and safety of retapamulin ointment as treatment of impetigo: randomized double-blind multicentre placebo-controlled trial

[2] Successful termination of a furunculosis outbreak due to lukS-lukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002-2005

[3] Measured versus self-reported compliance with doxycycline therapy for chlamydia-associated syndromes: high therapeutic success rates despite poor compliance

[4] Double-blind comparison of trovafloxacin and doxycycline in the treatment of uncomplicated Chlamydial urethritis and cervicitis. Trovafloxacin Chlamydial Urethritis/Cervicitis Study Group

[5] Single-dose azithromycin for Chlamydia in pregnant women

[6] Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori

[7] Comparison of PCR, Fluorescent in Situ Hybridization and Blood Cultures for Detection of Bacteremia in Children and Adolescents During Antibiotic Therapy

[8] Antibiotics to prevent infection in patients with dog bite wounds: a meta-analysis of randomized trials

[9] Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis

[10] Chlamydia in pregnancy: a randomized trial of azithromycin and erythromycin

[11] Epidemiology and clinical outcomes of patients with multiresistant Pseudomonas aeruginosa

[12] The effective period of preventive antibiotic action in experimental incisions and dermal lesions

[13] Prospective randomized double blind placebo-controlled evaluation of azithromycin for treatment of cat-scratch disease

[14] Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection

[15] Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus

[16] Community-acquired purulent meningitis: a review of 1,316 cases during the antibiotic era, 1954-1976

[17] Recurrent erysipelas: 47 cases

[18] Randomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient

[19] The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections

[20] A comparative study of two different regimens of sparfloxacin versus doxycycline in the treatment of non-gonococcal urethritis in men

[21] Treatment of febrile neutropenia: what is new?

[22] 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America

[23] Probiotics in man and animals

[24] Prophylactic and preventive antibiotic therapy: timing, duration and economics

[25] Comparison of clindamycin, rifampin, tetracycline, metronidazole, and penicillin for efficacy in prevention of experimental gas gangrene due to Clostridium perfringens

[26] A single center observational study on emergency department clinician non-adherence to clinical practice guidelines for treatment of uncomplicated urinary tract infections

[27] Rapid resolution of cellulitis in patients managed with combination antibiotic and anti-inflammatory therapy

[28] Contemporary antimicrobial susceptibility patterns of bacterial pathogens commonly associated with febrile patients with neutropenia

[29] Antibiotic prophylaxis and the risk of surgical site infections following total hip arthroplasty: timely administration is the most important factor

[30] Efficacy and safety of azithromycin versus lymecyline in the treatment of genital chlamydial infections in women

[31] Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials

[32] Empirical antibiotic choice for the seriously ill patient: are minimization of selection of resistant organisms and maximization of individual outcome mutually exclusive?

[33] Chlamydial cervicitis and urethritis: single dose treatment compared with doxycycline for seven days in community based practises

[34] Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis

[35] Treatment of plague with gentamicin or doxycycline in a randomized clinical trial in Tanzania

[36] Inappropriate antibiotic use in soft tissue infections

[37] Penicillin to prevent recurrent leg cellulitis

[38] Duodenal infusion of donor feces for recurrent Clostridium difficile

[39] Early identification of neutropenic patients at risk of grampositive bacteraemia and the impact of empirical administration of vancomycin

[40] Community-acquired bacterial meningitis in adults

[41] Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis

[42] Cefepime or carbapenem treatment for febrile neutropenia as a single agent is as effective as a combination of 4th-generation cephalosporin + aminoglycosides: comparative study

[43] Traumatic cerebrospinal fluid leakage: risk factors and the use of prophylactic antibiotics

[44] A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia

[45] Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone

[46] Prophylactic oral antibiotics for low-risk dog bite wounds

[47] Relapse of erysipelas following treatment with prednisolone or placebo in addition to antibiotics: a 1-year follow-up

[48] Application of the IDSA guidelines for the use of antimicrobial agents in neutropenic patients: impact on reducing the use of glycopeptides

[49] Recurrence of lymphoedema-associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study

[50] Multinational cooperation in trials and guidelines dealing with febrile neutropenia

[51] Methicillin-resistant S. aureus infections among patients in the emergency department

[52] Approach to the patient with presumed cellulitis

[53] Compliance with doxycycline therapy in sexually transmitted diseases clinics

[54] Criteria for response in patients in clinical trials of empiric antibiotic regimens for febrile neutropenia. Is there agreement?

[55] Managing antibiotic use--impact of infection control

[56] Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs)

[57] Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial

[58] Introduction to the Australian consensus guidelines for the management of neutropenic fever in adult cancer patients, 2010/2011. Australian Consensus Guidelines 2011 Steering Committee

[59] Azithromycin in the treatment of chlamydial cervicitis and eradication of Ureaplasma urealyticum in female lower genital tract

[60] Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy

[61] Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines

[62] Challenges in the diagnosis and management of neonatal sepsis

[63] Treatment of bubonic plague with sulfonamides and antibiotics

[64] Therapeutic drug monitoring of amikacin in septic patients

[65] Azithromycin or Doxycycline for Asymptomatic Rectal Chlamydia trachomatis

[66] Immediate and long-term efficacy of systemic antibiotics for eradicating nasal colonization with Staphylococcus aureus

[67] Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections

[68] Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric)

[69] Fidaxomicin versus vancomycin for Clostridium difficile infection

[70] Determinants of amikacin first peak concentration in critically ill patients

[71] Antibiotic prescribing over the last 16 years: fewer antibiotics but the spectrum is broadening

[72] Invasive Gram-negative bacilli are frequently resistant to standard antibiotics for children admitted to hospital in Kilifi, Kenya

[73] Lack of antimicrobial resistance in Yersinia pestis isolates from 17 countries in the Americas, Africa, and Asia

[74] Successful treatment of Acinetobacter meningitis with intrathecal polymyxin E

[75] Typhoid outbreak in Songkhla, Thailand 2009-2011: clinical outcomes, susceptibility patterns, and reliability of serology tests

[76] Impetigo contagiosa III. Comparative efficacy of oral erythromycin and topical mupirocin

[77] Lymphatic filariasis and onchocerciasis

[78] Old antibiotics for infections in critically ill patients

[79] Multidrug-resistant typhoid fever